Serum eosinophilic cationic protein and high sensitive C-reactive protein as alternative parameters for differentiation of severity stages and monitoring control in bronchial asthma patients

Background: High sensitive C-reactive protein (hs-CRP) and eosinophilic cationic protein (ECP) have been shown to be associated with asthma in recent studies. However, the relationship between hs-CRP and the control of asthma has not been clearly identified yet. Patients and methods: Thirty patients...

Full description

Bibliographic Details
Main Authors: Ashraf E. Sileem, Sameh Embarak, Mahmoud S. Meleha
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-10-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0422763814001514
_version_ 1818539405487374336
author Ashraf E. Sileem
Sameh Embarak
Mahmoud S. Meleha
author_facet Ashraf E. Sileem
Sameh Embarak
Mahmoud S. Meleha
author_sort Ashraf E. Sileem
collection DOAJ
description Background: High sensitive C-reactive protein (hs-CRP) and eosinophilic cationic protein (ECP) have been shown to be associated with asthma in recent studies. However, the relationship between hs-CRP and the control of asthma has not been clearly identified yet. Patients and methods: Thirty patients with newly-diagnosed bronchial asthma and 20 healthy individuals were enrolled in this study. In addition to medical history and physical examination, asthma was assessed according to the Global Initiative for Asthma (GINA) guidelines. Respiratory function tests (RFT), serum hs-CRP and ECP levels, serum total IgE levels, circulating eosinophil count (CE) and asthma control test (ACT) were performed for all subjects. Results: Serum ECP, serum hs-CRP, serum total IgE and CE were significantly higher (p < 0.01, 0.01, 0.05 and 0.05, respectively), while forced expiratory volume in 1 s (FEV1 %) and ACT were significantly lower (p < 0.05) in asthmatic patients compared to the control group. In all patients with bronchial asthma, serum levels of hs-CRP and ECP showed significant positive correlations with asthma severity (hs-CRP, rs = 0.59, p < 0.01; ECP, rs = 0.63, p < 0.01, respectively) but, significant negative correlations with ACT (hs-CRP, rs = −0.53, p < 0.05; ECP, rs = −0.62, p < 0.01, respectively) and FEV1 % (hs-CRP, rs = −0.46, p < 0.05; ECP, rs = −0.57, p < 0.01, respectively). Serum ECP and hs-CRP levels showed significant fall (p < 0.01and p < 0.05, respectively), while, FEV1 % and ACT showed significant increase (p < 0.05) in asthmatic patients who were followed up after 2 months of therapy. Conclusion: Coupling measurements of serum levels of both ECP and hs-CRP may add a benefit in determining the severity and monitoring of the control of bronchial asthma.
first_indexed 2024-12-11T21:41:36Z
format Article
id doaj.art-1aeffda92b58408b97f97a58364b7a6c
institution Directory Open Access Journal
issn 0422-7638
language English
last_indexed 2024-12-11T21:41:36Z
publishDate 2014-10-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Egyptian Journal of Chest Disease and Tuberculosis
spelling doaj.art-1aeffda92b58408b97f97a58364b7a6c2022-12-22T00:49:49ZengWolters Kluwer Medknow PublicationsEgyptian Journal of Chest Disease and Tuberculosis0422-76382014-10-0163476577010.1016/j.ejcdt.2014.07.001Serum eosinophilic cationic protein and high sensitive C-reactive protein as alternative parameters for differentiation of severity stages and monitoring control in bronchial asthma patientsAshraf E. Sileem0Sameh Embarak1Mahmoud S. Meleha2Chest Department, Zagazig University, EgyptChest Department, Zagazig University, EgyptClinical Pathology Department, Ainshams University, EgyptBackground: High sensitive C-reactive protein (hs-CRP) and eosinophilic cationic protein (ECP) have been shown to be associated with asthma in recent studies. However, the relationship between hs-CRP and the control of asthma has not been clearly identified yet. Patients and methods: Thirty patients with newly-diagnosed bronchial asthma and 20 healthy individuals were enrolled in this study. In addition to medical history and physical examination, asthma was assessed according to the Global Initiative for Asthma (GINA) guidelines. Respiratory function tests (RFT), serum hs-CRP and ECP levels, serum total IgE levels, circulating eosinophil count (CE) and asthma control test (ACT) were performed for all subjects. Results: Serum ECP, serum hs-CRP, serum total IgE and CE were significantly higher (p < 0.01, 0.01, 0.05 and 0.05, respectively), while forced expiratory volume in 1 s (FEV1 %) and ACT were significantly lower (p < 0.05) in asthmatic patients compared to the control group. In all patients with bronchial asthma, serum levels of hs-CRP and ECP showed significant positive correlations with asthma severity (hs-CRP, rs = 0.59, p < 0.01; ECP, rs = 0.63, p < 0.01, respectively) but, significant negative correlations with ACT (hs-CRP, rs = −0.53, p < 0.05; ECP, rs = −0.62, p < 0.01, respectively) and FEV1 % (hs-CRP, rs = −0.46, p < 0.05; ECP, rs = −0.57, p < 0.01, respectively). Serum ECP and hs-CRP levels showed significant fall (p < 0.01and p < 0.05, respectively), while, FEV1 % and ACT showed significant increase (p < 0.05) in asthmatic patients who were followed up after 2 months of therapy. Conclusion: Coupling measurements of serum levels of both ECP and hs-CRP may add a benefit in determining the severity and monitoring of the control of bronchial asthma.http://www.sciencedirect.com/science/article/pii/S0422763814001514Eosinophilic cationic proteinHigh sensitive C-reactive proteinBronchial asthma
spellingShingle Ashraf E. Sileem
Sameh Embarak
Mahmoud S. Meleha
Serum eosinophilic cationic protein and high sensitive C-reactive protein as alternative parameters for differentiation of severity stages and monitoring control in bronchial asthma patients
Egyptian Journal of Chest Disease and Tuberculosis
Eosinophilic cationic protein
High sensitive C-reactive protein
Bronchial asthma
title Serum eosinophilic cationic protein and high sensitive C-reactive protein as alternative parameters for differentiation of severity stages and monitoring control in bronchial asthma patients
title_full Serum eosinophilic cationic protein and high sensitive C-reactive protein as alternative parameters for differentiation of severity stages and monitoring control in bronchial asthma patients
title_fullStr Serum eosinophilic cationic protein and high sensitive C-reactive protein as alternative parameters for differentiation of severity stages and monitoring control in bronchial asthma patients
title_full_unstemmed Serum eosinophilic cationic protein and high sensitive C-reactive protein as alternative parameters for differentiation of severity stages and monitoring control in bronchial asthma patients
title_short Serum eosinophilic cationic protein and high sensitive C-reactive protein as alternative parameters for differentiation of severity stages and monitoring control in bronchial asthma patients
title_sort serum eosinophilic cationic protein and high sensitive c reactive protein as alternative parameters for differentiation of severity stages and monitoring control in bronchial asthma patients
topic Eosinophilic cationic protein
High sensitive C-reactive protein
Bronchial asthma
url http://www.sciencedirect.com/science/article/pii/S0422763814001514
work_keys_str_mv AT ashrafesileem serumeosinophiliccationicproteinandhighsensitivecreactiveproteinasalternativeparametersfordifferentiationofseveritystagesandmonitoringcontrolinbronchialasthmapatients
AT samehembarak serumeosinophiliccationicproteinandhighsensitivecreactiveproteinasalternativeparametersfordifferentiationofseveritystagesandmonitoringcontrolinbronchialasthmapatients
AT mahmoudsmeleha serumeosinophiliccationicproteinandhighsensitivecreactiveproteinasalternativeparametersfordifferentiationofseveritystagesandmonitoringcontrolinbronchialasthmapatients